HeyJaredThe Executive Espresso
The Executive Espresso is a fast-paced podcast where Australia’s top executive leaders share their leadership philosophies, decision-making strategies, and career insights - all in the time it takes to enjoy a coffee.
- Indexed episodes, last 90 days
- 3
- Latest publication
- Aug 31, 2026
- Audience
- Checking…
- Earliest in this view
- Aug 3, 2026
Latest episodes
He reached the top, and then realised what it had cost him (opens the original)
Read excerpt
He spent years advising boards on major decisions. Then he became the person who had to make them, and live with what happened next. Mike Ferraro built his career across law, investment banking and corporate leadership before becoming Chief Executive Officer of Alumina Limited, where he led the company through major strategic change and ultimately its sale to Alcoa. Today, he sits on boards including Australian Red Cross Lifeblood, Citywide Service Solutions and Firmus Technologies. Mike Ferraro
What Bellroy Got Right That Most Startups Get Wrong (opens the original)
Read excerpt
They started with nine ideas. Most were expected to fail. One became Bellroy. Sixteen years later, Bellroy has grown from selling seven wallets a day to building products recognised by customers around the world, working with companies including Apple and Qantas, and preparing to open its first Melbourne retail store. Lina Calabria, Co Founder and CEO of Bellroy, joins The Executive Espresso to talk about what happens when engineering, product design and patience come together This is not the us
No One Prepares You For This: Inside a CEO's Hardest Year (opens the original)
Read excerpt
She helped deliver Australia's COVID vaccine to every state in the country. Now she's building something this country has never built before. Dr Bev Menner, CEO of Cell Therapies, on the pressure nobody sees, the trust nobody hands you, and the hardest calls she's made when there was no playbook to follow.Dr Bev Menner is the CEO of Cell Therapies, Australia's only commercial-scale facility for manufacturing living cell and gene therapies. She spent the first half of her career as a cancer resea
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.